Iridian Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$4.93M |
| 2 |
BILL Holdings
BILL
|
+$4.86M |
| 3 |
Rentokil
RTO
|
+$4.86M |
| 4 |
Hilton Grand Vacations
HGV
|
+$4.76M |
| 5 |
Herbalife
HLF
|
+$2.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$52.3M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$8.51M |
| 3 |
Flex
FLEX
|
+$4.16M |
| 4 |
LPL Financial
LPLA
|
+$3.64M |
| 5 |
Gen Digital
GEN
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.59% |
| 2 | Technology | 14.81% |
| 3 | Healthcare | 12.76% |
| 4 | Consumer Staples | 9.67% |
| 5 | Financials | 6.32% |
Similar funds
Iridian Asset Management's Q2 2024 Portfolio in Review
As of Q2 2024, Iridian Asset Management held 56 positions worth $443M, down 13% from $510M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Iridian Asset Management withdrew a net $50.5M in Q2 2024, closing 5 positions and reducing 24 holdings. Its most notable exit was Stericycle Inc, an estimated $8.51M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Iridian Asset Management opened a new position in TG Therapeutics worth $700K.
- Iridian Asset Management's largest Q2 2024 buy was TG Therapeutics: 39,357 shares worth $700K.
- Iridian Asset Management added most to Charles River Laboratories in Q2 2024, an estimated $4.93M increase.
- Iridian Asset Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $52.3M.
- Iridian Asset Management fully exited Stericycle Inc in Q2 2024, selling an estimated $8.51M.
- Iridian Asset Management's ten largest holdings make up 57% of its $443M portfolio in Q2 2024.
- Iridian Asset Management opened 1 new position and closed 5 in Q2 2024.
- Iridian Asset Management's portfolio value fell 13% quarter-over-quarter to $443M.
Based on Iridian Asset Management's 13F filing for Q2 2024, filed 26 Jul 2024.